X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13944) 13944
Publication (916) 916
Book Review (95) 95
Magazine Article (39) 39
Dissertation (38) 38
Book Chapter (22) 22
Paper (12) 12
Conference Proceeding (8) 8
Data Set (5) 5
Reference (4) 4
Web Resource (3) 3
Newspaper Article (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atorvastatin (9507) 9507
humans (8225) 8225
male (5965) 5965
index medicus (5901) 5901
female (4872) 4872
statins (4542) 4542
atorvastatin calcium (4513) 4513
middle aged (4129) 4129
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3336) 3336
aged (3134) 3134
cholesterol (2682) 2682
cardiac & cardiovascular systems (2652) 2652
simvastatin (2643) 2643
pyrroles - therapeutic use (2640) 2640
heptanoic acids - therapeutic use (2637) 2637
pharmacology & pharmacy (2435) 2435
animals (2244) 2244
treatment outcome (2082) 2082
adult (2066) 2066
pyrroles - pharmacology (1693) 1693
heptanoic acids - pharmacology (1688) 1688
atherosclerosis (1658) 1658
risk factors (1612) 1612
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1607) 1607
pravastatin (1600) 1600
cholesterol, ldl - blood (1544) 1544
anticholesteremic agents - therapeutic use (1467) 1467
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1382) 1382
risk (1376) 1376
peripheral vascular disease (1343) 1343
pyrroles - administration & dosage (1334) 1334
heptanoic acids - administration & dosage (1332) 1332
prevention (1317) 1317
therapy (1279) 1279
lipids (1256) 1256
hypercholesterolemia (1209) 1209
medicine, general & internal (1156) 1156
coronary-heart-disease (1151) 1151
rats (1124) 1124
hypercholesterolemia - drug therapy (1123) 1123
inflammation (1123) 1123
rosuvastatin (1123) 1123
statin (1099) 1099
disease (1056) 1056
antilipemic agents (1027) 1027
analysis (1023) 1023
dose-response relationship, drug (1021) 1021
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (981) 981
cardiovascular disease (893) 893
care and treatment (886) 886
cardiovascular (877) 877
c-reactive protein (876) 876
cardiovascular-disease (871) 871
time factors (865) 865
drug therapy, combination (860) 860
drug therapy (859) 859
mortality (855) 855
cardiovascular diseases (850) 850
myocardial-infarction (842) 842
efficacy (827) 827
research (823) 823
double-blind method (805) 805
prospective studies (804) 804
cholesterol - blood (788) 788
abridged index medicus (773) 773
statin therapy (770) 770
safety (750) 750
mice (744) 744
simvastatin - therapeutic use (741) 741
expression (712) 712
events (692) 692
coronary heart disease (684) 684
oxidative stress (668) 668
lipids - blood (666) 666
anticholesteremic agents - administration & dosage (658) 658
follow-up studies (650) 650
aged, 80 and over (647) 647
metaanalysis (647) 647
low density lipoproteins (646) 646
diabetes (643) 643
pyrroles - adverse effects (641) 641
triglycerides - blood (641) 641
heptanoic acids - adverse effects (639) 639
cardiovascular agents (637) 637
ezetimibe (635) 635
cardiovascular diseases - prevention & control (630) 630
medicine, research & experimental (619) 619
rosuvastatin calcium (619) 619
anticholesteremic agents - pharmacology (590) 590
cholesterol, hdl - blood (588) 588
coa reductase inhibitors (575) 575
biochemistry & molecular biology (568) 568
acute coronary syndromes (565) 565
hyperlipidemias - drug therapy (564) 564
hypertension (554) 554
biomarkers - blood (545) 545
health aspects (545) 545
retrospective studies (545) 545
endocrinology & metabolism (543) 543
cardiology (542) 542
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13124) 13124
Spanish (171) 171
Russian (166) 166
German (137) 137
Chinese (135) 135
French (89) 89
Japanese (44) 44
Polish (28) 28
Korean (27) 27
Persian (23) 23
Portuguese (22) 22
Hungarian (21) 21
Turkish (20) 20
Italian (13) 13
Croatian (8) 8
Ukrainian (7) 7
Czech (6) 6
Swedish (5) 5
Dutch (4) 4
Norwegian (4) 4
Danish (3) 3
Lithuanian (3) 3
Slovenian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Heart Journal, ISSN 1349-2365, 2019
The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin... 
Atorvastatin
Journal Article
Journal of Drug Delivery Science and Technology, ISSN 1773-2247, 12/2012, Volume 22, Issue 6, pp. 505 - 510
The present study comprises the development and evaluation of the buccoadhesive bilayer Atorvastatin calcium (ATC) tablet. ATC belongs to class of HMG Co-A... 
Atorvastatin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
by Cao, Z and Wang, Y and Xiao, L and Liu, Z and Zheng, Y
Chinese Journal of Bioprocess Engineering, ISSN 1672-3678, 01/2013, Volume 11, Issue 1, pp. 17 - 22
t-butyl 6-cyano-(3/R,5R)-dihydroxyhexanoate, a key chiral building block for atorvastatin, was synthesized through asymmetric reduction of... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 08/2019, Volume 101, pp. 707 - 708
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 4/2015, Volume 41, Issue 4, pp. 594 - 604
Journal Article
10/2011
Drugs account for 1-2% of all cases of pancreatitis. A 58-year-old man was prescribed atorvastatin 10 mg for 6 months for hyperlipidemia. He developed acute... 
pancreatitis | Adverse drug reaction | atorvastatin
Web Resource
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 11/2017, Volume 143, Issue 3, pp. 359 - 374
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 02/2019, Volume 164, pp. 258 - 267
Statins, HMG-CoA reductase inhibitors, are considered the first line treatment of hyperlipidemia to reduce the risk of atherosclerotic cardiovascular diseases.... 
Obese subjects from GBS | Hyperlipidemic plasma | Simvastatin and metabolite | Rosuvastatin | Atorvastatin and metabolites | LC–MS/MS | MS-MS METHOD | LC-MS/MS | CHEMISTRY, ANALYTICAL | ACID | SIMULTANEOUS QUANTITATION | PHARMACOLOGY & PHARMACY | SIMULTANEOUS QUANTIFICATION | Simvastatin - therapeutic use | Gastric Bypass | Chromatography, High Pressure Liquid - methods | Hyperlipidemias - blood | Rosuvastatin Calcium - therapeutic use | Humans | Middle Aged | Male | Simvastatin - pharmacology | Obesity - blood | Simvastatin - blood | Atherosclerosis - etiology | Adult | Female | Atorvastatin - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Rosuvastatin Calcium - blood | Tandem Mass Spectrometry - methods | Hyperlipidemias - complications | Obesity - surgery | Tandem Mass Spectrometry - instrumentation | Reproducibility of Results | Obesity - complications | Hyperlipidemias - drug therapy | Rosuvastatin Calcium - pharmacology | Atorvastatin - therapeutic use | Postoperative Period | Chromatography, High Pressure Liquid - instrumentation | Atorvastatin - pharmacology | Calibration | Simvastatin - analogs & derivatives | Atorvastatin - analogs & derivatives | Atherosclerosis - prevention & control | Preoperative Period | Obesity | Medical research | Simvastatin | Gastric bypass | Organic acids | Cardiovascular agents | Antilipemic agents | Metabolites | Analysis | Formic acid | Medicine, Experimental | Nitriles
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2016, Volume 504, Issue 1-2, pp. 70 - 79
Journal Article
NEUROLOGY, ISSN 0028-3878, 08/2016, Volume 87, Issue 7, pp. 746 - 746
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2473 - 2481
Summary Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | PREVENTION | RISK | INTOLERANCE | PARTICIPANTS | Hematologic Diseases - chemically induced | Hypolipidemic Agents - adverse effects | Atorvastatin - adverse effects | Double-Blind Method | Nocebo Effect | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Atorvastatin - administration & dosage | Sleep Wake Disorders | Early Termination of Clinical Trials | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Lymphatic Diseases - chemically induced | Hypolipidemic Agents - administration & dosage | Hypertension - complications | Adult | Female | Hypercholesterolemia - prevention & control | Aged | Muscular Diseases - chemically induced | Clinical trials | Medicine, Experimental | Complications and side effects | Medical research | Epidemiology | Statins | Analysis | Cardiac patients | Sexual disorders | Risk factors | Myocardial infarction | Heart | Therapy | Laboratories | Funding | Physicians | Disorders | Impairment | Cognitive ability | Lipids | Cardiovascular disease | Angina | Matching | Connective tissues | Disturbance | Heart diseases | Public health | Hypertension | Medical personnel | Lymphatic system | Fasting | Effectiveness | Kidneys | Health risks | Erectile dysfunction | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Doctors | Side effects | Sleep | Atorvastatin | Infarction | Health risk assessment | Cardiovascular diseases | Kidney transplantation | Clinical Medicine | management | clinical-trials | intolerance | risk | cardiovascular-disease | Klinisk medicin | General & Internal Medicine | prevention | participants
Journal Article